Skip to main content

Medictation: Analysis of Attentional Control in Regards to Medication and Meditation

1 January 2013


[From the introduction]

Side effects of some Attention Deficit Hyperactivity Disorder (ADHD) medications (like Adderall) include rapid euphoria onset, decreased appetite, insomnia, abdomen pain, and headache. The nature and intensity of the effects range from drug to drug, with some having no reported effects, some having a “market level acceptable” degree, and some having mild to severe effects. No study reviewed lasted longer than four months (Hodgkins, et al., 2012).

Around the world the prescription and usage of ADHD medications rose threefold in the ten years between 1993 and 2003 and the amount of capital flowing into that market has risen nine-fold (Scheffler, Hinshaw, Modrek, & Levine, 2007). Along with this, the frequency of cases filed by the American Association of Poison Control Centers relating to abuse of ADHD medications rose by 76% between 1998-2005 for teenagers (Setlik, Bond, & Ho, 2009).

The aim of this thesis is to analyze the mechanisms of action for leading prescription ADHD drugs and meditative practice through the intersected lens of neuroscience, clinical, and cognitive psychology research. Central to this goal will be the analysis of how these topics shed light on the development and behavior of attentional control. Science makes a promise to use its outcomes to build a better society and future. The progress from these research fields and the current clinical treatment of ADD/ADHD demand matching.


File nameDate UploadedVisibilityFile size
Main File
18 Mar 2020
191 kB